Literature DB >> 11726306

Sixteen rare sequence variants of the hMLH1 and hMSH2 genes found in a cohort of 254 suspected HNPCC (hereditary non-polyposis colorectal cancer) patients: mutations or polymorphisms?

Y Müller-Koch1, R Kopp, P Lohse, G Baretton, A Stoetzer, D Aust, J Daum, B Kerker, M Gross, W Dietmeier, E Holinski-Feder.   

Abstract

5-8% of all colorectal cancer cases are assumed to be due to germline mutations in DNA mismatch repair genes. Mutation analysis of these genes in affected families enables one to identify subjects with an inborn susceptibility to colorectal tumorogenesis and to offer presymptomatic testing to family members at risk, provided that the mutation detected is a truncating one or a missense mutation that has either been judged as disease causing in other families or segregates with the disease and results in a microsatellite instability of the corresponding tumor. Segregation analysis within the family or microsatellite analysis of the tumor is, however, not always possible. In these cases, assessment of the relevance of the sequence variation identified is very difficult. On the other hand, discrimination between inactivating mutations and innocuous sequence polymorphisms is of extreme importance for clinical and genetic counseling of affected families. Here we report 16 rare sequence variants of the hMLH1 and hMSH2 genes including 11 different missense variations found in a cohort of 254 suspected HNPCC patients. We provide evidence, that missense variations in hMLH1 do not necessarily result in microsatellite instability of the corresponding tumor DNA. These patients would have been missed had one followed the recommendations of using only microsatellite analysis for the selection of patients at high risk of hereditary non-polyposis colorectal cancer for mutation analysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11726306

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  9 in total

1.  The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumors.

Authors:  Fabiola Medeiros; Noralane M Lindor; Fergus J Couch; W Edward Highsmith
Journal:  J Mol Diagn       Date:  2012-03-13       Impact factor: 5.568

2.  Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies.

Authors:  Karin Hardt; Sven Boris Heick; Beate Betz; Timm Goecke; Haniyeh Yazdanparast; Robin Küppers; Kati Servan; Verena Steinke; Nils Rahner; Monika Morak; Elke Holinski-Feder; Christoph Engel; Gabriela Möslein; Hans-Konrad Schackert; Magnus von Knebel Doeberitz; Christian Pox; Johannes H Hegemann; Brigitte Royer-Pokora
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

Review 3.  The role of epigenetics in Lynch syndrome.

Authors:  Megan P Hitchins
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

4.  The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype.

Authors:  Chau-To Kwok; Ingrid P Vogelaar; Wendy A van Zelst-Stams; Arjen R Mensenkamp; Marjolijn J Ligtenberg; Robert W Rapkins; Robyn L Ward; Nicolette Chun; James M Ford; Uri Ladabaum; Wendy C McKinnon; Marc S Greenblatt; Megan P Hitchins
Journal:  Eur J Hum Genet       Date:  2013-10-02       Impact factor: 4.246

5.  A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry.

Authors:  Bryony A Thompson; David E Goldgar; Carol Paterson; Mark Clendenning; Rhiannon Walters; Sven Arnold; Michael T Parsons; Walsh Michael D; Steven Gallinger; Robert W Haile; John L Hopper; Mark A Jenkins; Loic Lemarchand; Noralane M Lindor; Polly A Newcomb; Stephen N Thibodeau; Joanne P Young; Daniel D Buchanan; Sean V Tavtigian; Amanda B Spurdle
Journal:  Hum Mutat       Date:  2012-10-11       Impact factor: 4.878

6.  Targeted deep-intronic sequencing in a cohort of unexplained cases of suspected Lynch syndrome.

Authors:  Dimitrij Frishman; Elke Holinski-Feder; Anke Marie Arnold; Monika Morak; Anna Benet-Pagès; Andreas Laner
Journal:  Eur J Hum Genet       Date:  2019-12-10       Impact factor: 4.246

7.  Splicing analyses for variants in MMR genes: best practice recommendations from the European Mismatch Repair Working Group.

Authors:  Monika Morak; Marta Pineda; Alexandra Martins; Pascaline Gaildrat; Hélène Tubeuf; Aurélie Drouet; Carolina Gómez; Estela Dámaso; Kerstin Schaefer; Verena Steinke-Lange; Udo Koehler; Andreas Laner; Julie Hauchard; Karine Chauris; Elke Holinski-Feder; Gabriel Capellá
Journal:  Eur J Hum Genet       Date:  2022-06-09       Impact factor: 5.351

8.  Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry.

Authors:  Robyn L Ward; Timothy Dobbins; Noralane M Lindor; Robert W Rapkins; Megan P Hitchins
Journal:  Genet Med       Date:  2012-08-09       Impact factor: 8.822

9.  Lynch syndrome associated with two MLH1 promoter variants and allelic imbalance of MLH1 expression.

Authors:  Luke B Hesson; Deborah Packham; Chau-To Kwok; Andrea C Nunez; Benedict Ng; Christa Schmidt; Michael Fields; Jason W H Wong; Mathew A Sloane; Robyn L Ward
Journal:  Hum Mutat       Date:  2015-04-17       Impact factor: 4.878

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.